IP Library Granted Patent US 12,521,238
Granted Patent B2
US 12,521,238 · App. 18/130,676 · Granted Jan 13, 2026

Replacement heart valve with reduced suturing

Inventors: William Morris Leonard Neethling (Booragoon, AU); Scott Bliss (Minneapolis, MN); Anthony Michael Macintyre (Claremont, AU); Wayne Paterson (Mendota Heights, MN)
Assignee: Anteris Technologies Corporation
A61F2/2418A61F2/2412A61F2/2433A61F2/2442A61L27/3604A61L27/3683A61F2/2415A61F2/86A61F2220/0075A61F2250/0036Y10T29/4998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,238
App. No.
18/130,676
Granted
Jan 13, 2026
Kind
B2
Abstract

A heart valve replacement device comprises a stent having a first end, a second end, an outer surface, and an inner surface, the inner surface defining a lumen; and a valve disposed within the lumen of the stent, the valve formed from a single sheet of tissue, the valve having an outer surface, an inner surface, and a thickness between the outer surface and the inner surface, the valve comprising at least three leaflets, wherein, the valve is attached to the stent with minimal sutures. The leaflets are formed with a curvilinear surface.

Claims (17)

1 . A method of manufacturing a replacement heart valve device, comprising:

inserting a single sheet of an acellular, collagen-based biomaterial between a lower portion and an upper portion of a mold, wherein the lower portion and the upper portion of the mold cooperate to provide:

at least three leaflet forming sections comprising: (i) at least three convex forming sections of the lower portion and (ii) at least three concave forming sections of the upper portion, wherein each leaflet forming section has a curvilinear surface that is bounded by three curvilinear edges; and

commissure regions between adjacent leaflet forming sections of the at least three leaflet forming sections,

wherein the lower portion of the mold comprises a body region that is a substantially flat surface area that is adjacent to and extending away from each of the convex forming sections and each of the commissure regions;

while the acellular, collagen-based biomaterial is in the mold, applying a cross-linking solution to the acellular, collagen-based biomaterial to facilitate cross-linking of the acellular, collagen-based biomaterial to thereby create a molded valve, wherein the molded valve comprises:

a body portion formed by the body region;

at least three leaflets connected to the body portion, wherein the at least three leaflets are each molded by the at least three leaflet forming sections and are cross-linked to maintain a molded curved three-dimensional shape with a concave profile; and

molded commissures between adjacent leaflets of the at least three leaflets;

inserting the molded valve into a lumen of a stent; and

securing the valve to the stent with sutures.

2 . The method of claim 1 , wherein the molded valve is secured to the stent with between three and twenty sutures.

3 . The method of claim 1 , wherein the mold has a locking member for locking the upper portion relative to the lower portion.

4 . The method of claim 1 , wherein a spacer is inserted between the single sheet of the acellular, collagen-based biomaterial and at least one of the upper portion and the lower portion.

5 . The method of claim 1 , wherein the single sheet of the acellular, collagen-based biomaterial has varying thickness.

6 . The method of claim 5 , wherein the single sheet of the acellular, collagen-based biomaterial was cut with a cutting device to vary the thickness.

7 . The method of claim 1 , wherein each curvilinear edge intersects with two other curvilinear edges of the three curvilinear edges.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: NEETHLING, WILLIAM MORRIS LEONARD; BLISS, SCOTT; MACINTYRE, ANTHONY MICHAEL; PATERSON, WAYNE
To: ADMEDUS CORPORATION
Reel/Frame 067138/0544 →
CHANGE OF NAME Recorded Apr 17, 2024
From: ADMEDUS CORPORATION
To: ANTERIS TECHNOLOGIES CORPORATION
Reel/Frame 067142/0911 →
Continuity (3)
Division 16129235 · Sep 12, 2018
Provisional Application 62574410 · Oct 19, 2017
Related Publication 20230255757A1 · Aug 17, 2023
References Cited (123)
US 4624822A · Arru et al. · 1986 [cited by applicant]
US 5545215A · Duran · 1996 [cited by applicant]
US 5855601A · Bessler et al. · 1999 [cited by applicant]
US 6491511B1 · Duran et al. · 2002 [cited by applicant]
US 6682559B2 · Myers et al. · 2004 [cited by applicant]
US 7025780B2 · Gabbay · 2006 [cited by applicant]
US 7087079B2 · Navia et al. · 2006 [cited by applicant]
US 8778018B2 · Iobbi · 2014 [cited by applicant]
US 8790398B2 · Paniagua et al. · 2014 [cited by applicant]
US 8992599B2 · Thubrikar et al. · 2015 [cited by applicant]
US 9011525B2 · Claiborne, III et al. · 2015 [cited by applicant]
US 9095430B2 · Cunanan et al. · 2015 [cited by applicant]
US 9192470B2 · Cai et al. · 2015 [cited by applicant]
US 9205172B2 · Leonard Neethling et al. · 2015 [cited by applicant]
US 9259313B2 · Wheatley · 2016 [cited by applicant]
US 9301835B2 · Campbell et al. · 2016 [cited by applicant]
US 9554902B2 · Braido et al. · 2017 [cited by applicant]
US 9744037B2 · Kheradvar et al. · 2017 [cited by applicant]
US 9763780B2 · Morriss et al. · 2017 [cited by applicant]
US 11135059B2 · Hammer et al. · 2021 [cited by applicant]
US 11464635B2 · Reimer et al. · 2022 [cited by applicant]
US 20030069635A1 · Cartledge et al. · 2003 [cited by applicant]
US 20040254640A1 · Sutherland · 2004 [cited by examiner]
US 20050123582A1 · Sung et al. · 2005 [cited by applicant]
US 20050137687A1 · Salahieh et al. · 2005 [cited by applicant]
US 20050203614A1 · Forster et al. · 2005 [cited by applicant]
US 20050240262A1 · White · 2005 [cited by applicant]
US 20060020327A1 · Lashinski et al. · 2006 [cited by applicant]
US 20070027535A1 · Purdy, Jr. et al. · 2007 [cited by applicant]
US 20080288055A1 · Paul, Jr. · 2008 [cited by applicant]
US 20090112309A1 · Jaramillo et al. · 2009 [cited by applicant]
US 20100049313A1 · Alon et al. · 2010 [cited by applicant]
US 20100082094A1 · Quadri · 2010 [cited by examiner]
US 20100114307A1 · Agnew et al. · 2010 [cited by applicant]
US 20110066224A1 · White · 2011 [cited by applicant]
US 20110238167A1 · Dove et al. · 2011 [cited by applicant]
US 20120078356A1 · Fish et al. · 2012 [cited by applicant]
US 20120185038A1 · Fish et al. · 2012 [cited by applicant]
US 20120277855A1 · Lashinski et al. · 2012 [cited by applicant]
US 20130018458A1 · Yohanan et al. · 2013 [cited by applicant]
US 20130184811A1 · Rowe et al. · 2013 [cited by applicant]
US 20130197631A1 · Bruchman et al. · 2013 [cited by applicant]
US 20130204360A1 · Gainor · 2013 [cited by applicant]
US 20130310927A1 · Quintessenza · 2013 [cited by applicant]
US 20140005772A1 · Edelman et al. · 2014 [cited by applicant]
US 20140031924A1 · Bruchman et al. · 2014 [cited by applicant]
US 20140107772A1 · Li et al. · 2014 [cited by applicant]
US 20140277417A1 · Schraut et al. · 2014 [cited by applicant]
US 20140324160A1 · Benichou et al. · 2014 [cited by applicant]
US 20150134056A1 · Claiborne, III et al. · 2015 [cited by applicant]
US 20150142104A1 · Braido · 2015 [cited by applicant]
US 20150209141A1 · Braido et al. · 2015 [cited by applicant]
US 20150216663A1 · Braido et al. · 2015 [cited by applicant]
US 20150289973A1 · Braido et al. · 2015 [cited by applicant]
US 20150320556A1 · Levi et al. · 2015 [cited by applicant]
US 20160128831A1 · Zhou et al. · 2016 [cited by applicant]
US 20160135951A1 · Salahieh et al. · 2016 [cited by applicant]
US 20160143732A1 · Glimsdale · 2016 [cited by applicant]
US 20160158007A1 · Centola et al. · 2016 [cited by applicant]
US 20160175095A1 · Dienno et al. · 2016 [cited by applicant]
US 20160220365A1 · Backus et al. · 2016 [cited by applicant]
US 20160317293A1 · Matheny et al. · 2016 [cited by applicant]
US 20160331532A1 · Quadri · 2016 [cited by applicant]
US 20160367360A1 · Cartledge et al. · 2016 [cited by applicant]
US 20160367364A1 · Torrianni et al. · 2016 [cited by applicant]
US 20170049566A1 · Zeng et al. · 2017 [cited by applicant]
US 20170056170A1 · Zhu et al. · 2017 [cited by applicant]
US 20170119525A1 · Rowe et al. · 2017 [cited by applicant]
US 20170165053A1 · Buesseler et al. · 2017 [cited by applicant]
US 20170189174A1 · Braido et al. · 2017 [cited by applicant]
US 20170258585A1 · Marquez et al. · 2017 [cited by applicant]
US 20170312075A1 · Fahim et al. · 2017 [cited by applicant]
US 20180028312A1 · Thill et al. · 2018 [cited by applicant]
US 20180228603A1 · Racchini et al. · 2018 [cited by applicant]
US 20200188099A1 · Dvorsky et al. · 2020 [cited by applicant]
US 20210212819A1 · Reed et al. · 2021 [cited by applicant]
US 20210212822A1 · Reed et al. · 2021 [cited by applicant]
US 20210212823A1 · Reed et al. · 2021 [cited by applicant]
CN 203736349 · 2014 [cited by applicant]
CN 104780952 · 2015 [cited by applicant]
CN 105662651 · 2016 [cited by applicant]
EP 2777618 · 2014 [cited by applicant]
EP 2967869 · 2016 [cited by applicant]
EP 3697343 · 2020 [cited by applicant]
JP 2001120582 · 2001 [cited by applicant]
JP 2002527191 · 2002 [cited by applicant]
JP 2005505343 · 2005 [cited by applicant]
JP 2008264553 · 2008 [cited by applicant]
JP 2012504031 · 2012 [cited by applicant]
JP 2015512288 · 2015 [cited by applicant]
JP 2015519187 · 2015 [cited by applicant]
JP 2017502750 · 2017 [cited by applicant]
KR 1020110043361 · 2011 [cited by applicant]
NL 1008349C2 · 1999 [cited by examiner]
WO 2001076510 · 2001 [cited by applicant]
WO 2003030776 · 2003 [cited by applicant]
WO WO2006026325A2 · 2006 [cited by examiner]
WO 2007013999 · 2007 [cited by applicant]
WO 2011072084 · 2011 [cited by applicant]
WO 2011109450 · 2011 [cited by applicant]
WO WO2013120082 · 2013 [cited by applicant]
WO 2014204807 · 2014 [cited by applicant]
WO 2015126712 · 2015 [cited by applicant]
WO 2015173794 · 2015 [cited by applicant]
WO 2017031155 · 2017 [cited by applicant]
WO 2019144036 · 2019 [cited by applicant]
Translation of NL 1008349 (Year: 1999). [cited by examiner]
IN Notice of Oral Hearing in Indian Appln. No. 202047020477, dated Dec. 13, 2023, 2 pages. [cited by applicant]
Office Action in Chinese Appln. No. 201880076903.4, dated Apr. 20, 2024, 22 pages (with English translation). [cited by applicant]
Office Action in Chinese Appln. No. 201880076903.4, dated Feb. 3, 2024, 18 pages (with English translation). [cited by applicant]
Office Action in European Appln. No. 23168310.3, dated Mar. 20, 2024, 7 pages. [cited by applicant]
Office Action in Japanese Appln. No. 2023-086917, dated Feb. 7, 2024, 6 pages (with English translation). [cited by applicant]
Knee Hiang Lim et al., Flat or Curved Pericardial Aortic Valve Cusps: A Finite Element Study, Journal of Heart Valve, vol. 13, No. 5 (Sep. 2004). [cited by applicant]
Search Report and Written Opinion for related PCT Application No. PCT/US2018/050669 mailed Nov. 26, 2018 (12 pages). [cited by applicant]
CN Office Action in Chinese Appln. No. 201880076903.4, dated Mar. 3, 2023, 18 pages (with English translation). [cited by applicant]
CN Office Action in Chinese Appln. No. 202310418412.6, dated Sep. 16, 2023, 7 pages. [cited by applicant]
EP Office Action in European Appln. No. 18779534.9, dated Jul. 31, 2023, 5 pages. [cited by applicant]
Extended European Search Report in European Appln. No. 23168310.3, dated Aug. 1, 2023, 8 pages. [cited by applicant]
JP Office Action in Japanese Appln. No. 2020-522323, dated Apr. 25, 2023, 7 pages (with English translation). [cited by applicant]
JP Office Action in Japanese Appln. No. 2020-522323, dated Jul. 19, 2022, 10 pages (with English translation). [cited by applicant]
JP Office Action in Japanese Appln. No. 2023-086917, dated Aug. 22, 2023, 6 pages (with English translation). [cited by applicant]
KR Notice of Allowance in Korean Appln. No. 10-2020-7014246, dated Sep. 22, 2023, 5 pages (with English translation). [cited by applicant]
Office Action in Japanese Appln. No. 2023-086917, dated Nov. 12, 2024, 6 pages (with English translation). [cited by applicant]